Drug-Resistant Infections: A Threat to Our Economic Future

by Olga Jonas, Franck Berthe, Francois Le Gall et al.
International Bank for Reconstruction and Development/The World Bank, September 2016

132 pp. 4.7 MB
http://pubdocs.worldbank.org/en/527731474225046104/AMR-Discussion-Draft-
Sept18updated.pdf
pic-001_resize

This report provides insights into the extent and broad patterns of the economic impacts of antimicrobial resistance (AMR) and their implications for poverty, should AMR continue to increase because of inadequate collective actions. Echoing other recent studies, this report underscores that the likely direct and indirect economic damage would be substantial. The annual costs could be as large as those of the global financial crisis that started in 2008. The costly impacts of AMR on GDP would be worse in two respects, however: they would be felt during the entire simulation period (which extends to 2050) and inequality between countries would increase because low-income countries would experience the largest shortfalls in economic growth.

(Visited 23 times, 1 visits today)
This entry was posted in Essential Medicines, General. Bookmark the permalink.